Clinical Trials Directory

Trials / Completed

CompletedNCT07460115

Comparison of Mean Duration of Analgesia Following the Administration of Bupivacaine With and Without Magnesium Sulphate in Ultrasound Guided Erector Spinae Plane Block in Modified Radical Mastectomy Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Gulab Devi Hospital · Academic / Other
Sex
Female
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

To compare mean duration of postoperative analgesia following the administration of bupivacaine with and without magnesium sulphate in erector spinae plane block in modified radical mastectomy patients.

Detailed description

There is a difference in mean duration of analgesia following the administration of bupivacaine with and without magnesium sulphate in erector spinae plane block in modified radical mastectomy patients.

Conditions

Interventions

TypeNameDescription
DRUGGroup B (bupivacaine)receive 20 ml of 0.25% bupivacaine on the operated side for the Erector Spinae Plane (ESP) block.
DRUGBupivacaine plus magnesium sulfate20 ml of 0.25% bupivacaine plus 250 mg of magnesium sulfate on each side.

Timeline

Start date
2025-05-28
Primary completion
2025-11-28
Completion
2025-11-28
First posted
2026-03-10
Last updated
2026-03-10

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07460115. Inclusion in this directory is not an endorsement.